New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Theravance Biopharma, Inc.
TBPH
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

448M

Biotechnology

Next Earning date - 24 Feb 2025

448M

Biotechnology

Next Earning date - 24 Feb 2025

9.12USD

Shape-0.18 ( -1.94%)
Market Closed (as of Feb 10, 21:18 EDT)
favorite-chart

Relative Strenght

76
favorite-chart

Volume Buzz

-24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated February 11, 2025
1W -6.17 % 1M 6.42 % 3M 2.36 % 1Y 6.29 %

Key Metrics

Shape
  • Market Cap

    448.47M


  • Shares Outstanding

    49.17M


  • Share in Float

    45.34M


  • Dividende

    0


  • Earning Date

    24 Feb 2025


  • Price Target

    9.12


  • Average Volume

    204180


  • Beta

    0.251


  • Range

    7.44-10.9


  • Industry

    Biotechnology


  • Website

    https://www.theravance.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TBPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.21
vs -0.43

Q1.23

arrow
arrow

N/A

-0.24
vs -0.24

Q2.23

arrow
arrow

N/A

-0.13
vs -0.04

Q3.23

arrow
arrow

N/A

-0.01
vs -0.21

Q4.23

arrow
arrow

+114%

0.03
vs -0.21

Q1.24

arrow
arrow

N/A

-0.09
vs -0.24

Q2.24

arrow
arrow

N/A

-0.13
vs -0.13

Q3.24

arrow
arrow

+100%

NA
vs -0.01

Q4.24

arrow
arrow

N/A

-0.18
vs 0.03

Q1.25

arrow
arrow

N/A

-0.22
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-2%

14.6M  vs 14.9M

Q1.23

arrow
arrow

-21%

10.4M  vs 13.2M

Q2.23

arrow
arrow

+24%

13.7M  vs 11.1M

Q3.23

arrow
arrow

+26%

15.7M  vs 12.5M

Q4.23

arrow
arrow

+20%

17.6M  vs 14.6M

Q1.24

arrow
arrow

+39%

14.5M  vs 10.4M

Q2.24

arrow
arrow

+4%

14.3M  vs 13.7M

Q3.24

arrow
arrow

+7%

16.9M  vs 15.7M

Q4.24

arrow
arrow

-3%

17.1M  vs 17.6M

Q1.25

arrow
arrow

+11%

16.1M  vs 14.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-3%

-0.03
vs 1.91

Q1.23

arrow
arrow

-6%

-0.06
vs -0.03

Q2.23

arrow
arrow

-6%

-0.06
vs -0.06

Q3.23

arrow
arrow

-4%

-0.04
vs -0.06

Q4.23

arrow
arrow

-4%

-0.04
vs -0.04

Q1.24

arrow
arrow

-6%

-0.06
vs -0.04

Q2.24

arrow
arrow

-9%

-0.09
vs -0.06

Q3.24

arrow
arrow

-7%

-0.07
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

128

128
vs 131

-2%

Q1.23

arrow
arrow

118

118
vs 128

-8%

Q2.23

arrow
arrow

122

122
vs 118

3%

Q3.23

arrow
arrow

115

115
vs 122

-6%

Q4.23

arrow
arrow

119

119
vs 115

3%

Q1.24

arrow
arrow

122

122
vs 119

3%

Q2.24

arrow
arrow

133

133
vs 122

9%

Q3.24

arrow
arrow

121

121
vs 133

-9%

Earnings Growth

Latest News